FormFactor
FORM Nasdaq Semiconductor Materials & Equipment Financials FY2016βFY2025
FormFactor's revenue rose 2.8% to $785 million in fiscal 2025. Its operating margin was 7.3%, down from 8.5% a year earlier. Free cash flow was $12 million, down 85.2%. It paid out $26 million in dividends and buybacks, 224% of free cash flow. The diluted share count fell 0.2%.
What FormFactor does
No business description yet.
- Legal name
- FormFactor, Inc.
- Fiscal year ends
- December 27, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001039399-26-000009
0001039399
Revenue and margins
FormFactor had $785M of revenue in fiscal 2025, up 2.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $11.7M in fiscal 2025, 1.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
FormFactor returned $26.2M to shareholders in fiscal 2025, 224% of free cash flow. The diluted share count fell 0.2%.
Value FormFactor yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $263M and divides by 78.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 67.5x Β· peers 71.0x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably FormFactor can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $276M | $238M | $328M | $360M | $275M |
| Debt incl. finance leases | $24.4M | $15.4M | $14.4M | $13.3M | $12.2M |
| Net debt / EBITDA | β1.8x | β2.4x | β2.5x | β3.5x | β2.7x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 162.9x | 94.8x | 196.6x | 155.0x | 109.5x |
| Current ratio | 3.5x | 3.2x | 4.4x | 4.6x | 4.5x |
| Quick ratio | 2.8x | 2.4x | 3.5x | 3.8x | 3.6x |
| Total assets | $1.0B | $1.0B | $1.1B | $1.1B | $1.2B |
| Total liabilities | $205M | $200M | $198M | $198M | $189M |
| Shareholders' equity | $816M | $808M | $909M | $948M | $1.0B |
| Net debt (β = net cash) | β$252M | β$223M | β$314M | β$347M | β$263M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$10.2M
6 insiders
Of sales under plans
70%
$7.1M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Mike SlessorCEO, Director | Sold plan | 17,510 | $104.73 | $1.8M | Form 4 |
| Sep 3, 2026 | Kelley Steven-WaissDirector | Sold | 2,100 | $96.10 | $0.2M | Form 4 |
| Aug 14, 2026 | Mike SlessorCEO, Director | Sold plan | 16,002 | $130.95 | $2.1M | Form 4 |
| Jul 15, 2026 | Mike SlessorCEO, Director | Sold plan | 4,735 | $118.31 | $0.6M | Form 4 |
| Jun 15, 2026 | Dennis Thomas StDirector | Sold | 2,800 | $151.49 | $0.4M | Form 4 |
| Jun 10, 2026 | Mike SlessorCEO, Director | Sold plan | 11,890 | $121.35 | $1.4M | Form 4 |
| Jun 2, 2026 | Sheri RhodesDirector | Sold | 6,328 | $125.40 | $0.8M | Form 4 |
| May 21, 2026 | Rebeca Obregon-JimenezDirector | Sold | 3,828 | $126.48 | $0.5M | Form 4 |
| May 20, 2026 | Brian C WhiteDirector | Sold | 3,250 | $126.00 | $0.4M | Form 4 |
| May 19, 2026 | Dennis Thomas StDirector | Sold | 1,000 | $115.84 | $0.1M | Form 4 |
| May 15, 2026 | Kelley Steven-WaissDirector | Sold | 5,400 | $125.60 | $0.7M | Form 4 |
| May 13, 2026 | Mike SlessorCEO, Director | Sold plan | 9,438 | $126.52 | $1.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | 1.7% | β4.3% | β5.2% |
| Altman Z'' | 8.10 | 8.45 | 8.85 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| FormFactor FORM | $7.8B | 2.8% | 7.3% | 1.5% | 6.8% | 67.5x | 5 | |
| Onto Innovation ONTO | $9.9B | 1.8% | 13.2% | 29.8% | 8.8% | 74.7x | 4 | Compare β |
| Advanced Energy AEIS | $9.2B | 21.4% | 9.3% | 7.0% | 13.6% | 40.3x | 6 | Compare β |
| Teradyne TER | $49.3B | 13.1% | 20.4% | 14.1% | 23.0% | 89.0x | 5 | Compare β |
| Entegris ENTG | $20.7B | β1.4% | 14.3% | 12.4% | 5.8% | 67.3x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $384M | $548M | $530M | $590M | $694M | $770M | $748M | $663M | $764M | $785M |
| Gross profit | $103M | $216M | $210M | $238M | $288M | $323M | $296M | $259M | $308M | $309M |
| Research and development | $57.5M | $73.8M | $75.0M | $81.5M | $89.0M | $101M | $109M | $116M | $122M | $116M |
| Operating income | β$47.9M | $46.3M | $36.1M | $49.7M | $83.8M | $98.0M | $54.9M | $82.8M | $64.8M | $57.1M |
| Interest expense | $2.4M | $4.5M | $3.3M | $1.9M | $0.9M | $0.6M | $0.6M | $0.4M | $0.4M | $0.5M |
| Pretax income | β$50.2M | $42.2M | $33.9M | $51.1M | $85.2M | $98.5M | $57.9M | $89.3M | $79.4M | $69.4M |
| Income tax | β$43.6M | $1.3M | β$70.1M | $11.7M | $6.7M | $14.6M | $7.1M | $6.9M | $9.8M | $13.0M |
| Net income | β$6.6M | $40.9M | $104M | $39.3M | $78.5M | $83.9M | $50.7M | $82.4M | $69.6M | $54.4M |
| Diluted EPS | β$0.10 | $0.55 | $1.38 | $0.51 | $0.99 | $1.06 | $0.65 | $1.05 | $0.89 | $0.69 |
| Diluted shares | 0.06B | 0.07B | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $17.4M | $86.3M | $68.7M | $121M | $169M | $139M | $132M | $64.6M | $118M | $115M |
| Capital expenditure | $11.5M | $17.8M | $19.9M | $20.8M | $55.9M | $66.5M | $65.3M | $56.0M | $38.4M | $104M |
| Free cash flow | $5.9M | $68.6M | $48.8M | $100M | $113M | $72.9M | $66.5M | $8.6M | $79.1M | $11.7M |
| Depreciation and amortization | $46.8M | $44.6M | $43.7M | $44.9M | $48.7M | $44.5M | $38.0M | $44.3M | $35.5M | $40.1M |
| Stock-based compensation | $11.7M | $16.3M | $17.8M | $23.2M | $23.8M | $29.4M | $31.3M | $38.6M | $39.8M | $38.6M |
| Acquisitions | $228M | $0.0M | $0.0M | $20.5M | $51.9M | $0.0M | $3.3M | $0.0M | $0.0M | $20.6M |
| Share buybacks | $0.0M | $19.0M | $0.0M | $0.0M | $0.0M | $24.0M | $82.3M | $19.8M | $53.3M | $26.2M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $19.0M | $0.0M | $0.0M | $0.0M | $24.0M | $82.3M | $19.8M | $53.3M | $26.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $101M | $140M | $149M | $221M | $255M | $276M | $238M | $328M | $360M | $275M |
| Total debt | $138M | $106M | $64.8M | $58.5M | $34.5M | $24.4M | $15.4M | $14.4M | $13.3M | $12.2M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $255M | $306M | $338M | $419M | $487M | $524M | $475M | $574M | $605M | $557M |
| Current liabilities | $82.7M | $92.2M | $103M | $137M | $155M | $149M | $150M | $131M | $131M | $124M |
| Inventory | $59.8M | $67.8M | $77.7M | $83.3M | $99.2M | $112M | $123M | $112M | $102M | $111M |
| Property and equipment, net | $42.7M | $46.8M | $54.1M | $58.7M | $104M | $147M | $190M | $204M | $210M | $259M |
| Total assets | $619M | $647M | $728M | $840M | $963M | $1.0B | $1.0B | $1.1B | $1.1B | $1.2B |
| Total liabilities | $218M | $188M | $148M | $199M | $219M | $205M | $200M | $198M | $198M | $189M |
| Shareholders' equity | $401M | $459M | $580M | $641M | $744M | $816M | $808M | $909M | $948M | $1.0B |
| Margins | ||||||||||
| Gross margin | 26.8% | 39.3% | 39.7% | 40.3% | 41.5% | 41.9% | 39.6% | 39.0% | 40.3% | 39.3% |
| Operating margin | β12.5% | 8.4% | 6.8% | 8.4% | 12.1% | 12.7% | 7.3% | 12.5% | 8.5% | 7.3% |
| EBITDA margin | β0.3% | 16.6% | 15.1% | 16.0% | 19.1% | 18.5% | 12.4% | 19.2% | 13.1% | 12.4% |
| Net margin | β1.7% | 7.5% | 19.6% | 6.7% | 11.3% | 10.9% | 6.8% | 12.4% | 9.1% | 6.9% |
| FCF margin | 1.5% | 12.5% | 9.2% | 17.0% | 16.4% | 9.5% | 8.9% | 1.3% | 10.4% | 1.5% |
| Returns | ||||||||||
| Return on capital | β | 10.4% | 7.9% | 7.9% | 15.4% | 15.4% | 8.4% | 12.9% | 9.5% | 6.8% |
| Return on capital employed | β11.5% | 8.5% | 6.1% | 7.5% | 11.1% | 11.7% | 6.4% | 9.0% | 6.5% | 5.4% |
| Return on equity | β1.9% | 9.5% | 20.0% | 6.4% | 11.3% | 10.8% | 6.3% | 9.6% | 7.5% | 5.5% |
| Return on assets | β1.4% | 6.5% | 15.1% | 5.0% | 8.7% | 8.5% | 5.0% | 7.8% | 6.2% | 4.6% |
| Growth | ||||||||||
| Revenue growth | 36.0% | 42.9% | β3.4% | 11.3% | 17.7% | 11.0% | β2.8% | β11.3% | 15.2% | 2.8% |
| Net income growth | β | β | 154.3% | β62.2% | 99.6% | 6.9% | β39.5% | 62.4% | β15.5% | β21.9% |
| EPS growth | β | β | 150.9% | β63.0% | 94.1% | 7.1% | β38.7% | 61.5% | β15.2% | β22.5% |
| FCF growth | β78.5% | 1,061.8% | β28.8% | 105.2% | 13.2% | β35.7% | β8.7% | β87.1% | 822.4% | β85.2% |
| Share count change | 12.3% | 14.3% | 1.3% | 2.8% | 2.2% | 0.2% | β1.2% | β0.1% | 0.4% | β0.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β0.4x | β1.1x | β1.7x | β1.7x | β1.8x | β2.4x | β2.5x | β3.5x | β2.7x |
| Debt / equity | 0.3x | 0.2x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β20.0x | 10.3x | 10.9x | 25.9x | 97.0x | 162.9x | 94.8x | 196.6x | 155.0x | 109.5x |
| Current ratio | 3.1x | 3.3x | 3.3x | 3.1x | 3.2x | 3.5x | 3.2x | 4.4x | 4.6x | 4.5x |
| Quick ratio | 2.4x | 2.6x | 2.5x | 2.5x | 2.5x | 2.8x | 2.4x | 3.5x | 3.8x | 3.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.0% | 3.2% | 3.8% | 3.5% | 8.1% | 8.6% | 8.7% | 8.5% | 5.0% | 13.2% |
| Stock comp / revenue | 3.0% | 3.0% | 3.4% | 3.9% | 3.4% | 3.8% | 4.2% | 5.8% | 5.2% | 4.9% |
| Payouts / FCF | 0.0% | 27.7% | 0.0% | 0.0% | 0.0% | 33.0% | 123.7% | 230.9% | 67.4% | 223.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 5.0 | 5.0 | 8.0 | 6.0 | 5.0 | 6.0 | 7.0 | 5.0 |
| Altman Z'' | 1.0 | 3.3 | 5.3 | 5.0 | 5.9 | 7.0 | 6.6 | 8.1 | 8.5 | 8.9 |
| Accruals ratio | β5.0% | β7.2% | 5.1% | β10.4% | β10.1% | β5.6% | β8.0% | 1.7% | β4.3% | β5.2% |
Source: SEC EDGAR XBRL filings (CIK 0001039399). Data updated October 17, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.